INFANTS' TYLENOL ORAL SUSPENSION OTC
Generic Name and Formulations:
Acetaminophen 160mg/5mL; cherry or grape flavor; alcohol-free.
McNeil Consumer Healthcare
Indications for INFANTS' TYLENOL ORAL SUSPENSION:
Minor aches and pain. Fever.
Dispense liquid slowly in mouth toward inner cheek. <24lbs or <2yrs: consult doctor. 24–35lbs or 2–3yrs: 5mL (160mg) every 4hrs; max 5 doses/24hrs.
Hepatic dysfunction. Reevaluate if severe sore throat persists >2 days with or followed by fever, headache, rash, nausea or vomiting. Discontinue if new symptoms occur, pain worsens >5 days, fever persists >3 days, or if redness or swelling is present.
Do not use with other acetaminophen-containing drugs. Caution with concomitant warfarin.
Susp (w. oral syringe)—1oz (grape); 2oz (cherry)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Immune Checkpoint Inhibitors for NSCLC: Current and Future Approaches
- Can A Consortium of Hospitals Help To Reduce Drug Prices?
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- Erdafitinib Granted FDA Breakthrough Therapy Designation for Urothelial Carcinoma
- NSCLC: Stratifying Patients With Complex EGFR Mutations
- Nivolumab Plus Ipilimumab Improves Overall Survival, ORR in Renal Cell Carcinoma
- Encorafenib, Binimetinib May Be Effective in BRAF-Mutant Melanoma
- CLL: Venetoclax Plus Rituximab Improves 2-Year PFS
- Confronting Racial Disparities in Prostate Cancer Survival Outcomes
- FDA Approves Front-Line Brentuximab Vedotin Plus Chemotherapy for Hodgkin Lymphoma